Skip to main content
Signal8

Equels Thomas K

SEC insider (Form 3/4/5 filer). CIK 0001450324. CEO & President at AIM ImmunoTech Inc. (AIM). 23 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in OCALA,, FL.

Companies Equels Thomas K has filed insider reports for

  • AIM ImmunoTech Inc. (AIM): Director, Officer, CEO & President
Equels Thomas K profile photo

Equels Thomas K

CIK: 0001450324

Transaction Breakdown

Open Market Buys (P)19 (82.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (4.3%)

Compensation grants

Other (G, F, J, C, D, …)3 (13.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AIM ImmunoTech Inc. logo
AIM

AIM ImmunoTech Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Oct 23, 2026
    Purchase
    Direct
    31.7K shares at avg. $0.16$5K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Oct 22, 2026
    Purchase
    Direct
    31.3K shares at avg. $0.16$5K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Sep 17, 2026
    Purchase
    Direct
    24K shares at avg. $0.21$5K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Sep 16, 2026
    Purchase
    Direct
    11K shares at avg. $0.21$2K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Sep 15, 2026
    Purchase
    Direct
    22K shares at avg. $0.22$5K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Sep 14, 2026
    Purchase
    Direct
    5.9K shares at avg. $0.22$1K
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Mar 12, 2026
    Conversion
    Direct
    25K shares-
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Mar 6, 2026
    Other

    Class G Warrants

    Direct
    50K shares-
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Mar 6, 2026
    Other

    Series G Convertible Preferred Stock

    Direct
    25 shares at avg. $25000.00-
  • AIM ImmunoTech Inc. logo
    AIM

    AIM ImmunoTech Inc.

    Jun 13, 2025
    Purchase
    Direct
    107 shares at avg. $7.70$823.579

1-10 of 23